. 2018 Jan 11;18:34. doi: 10.1186/s12879-017-2921-8

Table 1.

Chronic hepatitis B prevalence in the general population of 31 EU/EEA countries and the estimated number of infected cases

Country	Total Population	HBsAg prevalence			Estimated no. of CHB cases
Country	Total Population	%	Low 95% CI	High 95% CI	Central estimate	Lower estimate	Upper estimate
Austria	8,451,149	0.55	0.34	0.71	46,481	28,734	60,003
Belgium	11,161,642	0.7	0.4	1.2	78,131	44,647	133,940
Bulgaria	7,284,552	4.25	2.80	5.70	309,593	203,967	415,219
Croatia	4284,889^a	1.47	0.84	2.10	62,988	35,993	89,983
Cyprus	840,407^a	0.9	0.3	2	7564	2521	16,808
Czech Republic	10,516,125	0.70	0.43	0.98	73,613	45,219	103,058
Denmark	5,602,628	0.55	0.34	0.71	30,814	19,049	39,779
Estonia	1,320,174	0.58	0.42	0.74	7657	5545	9769
Finland	5,426,674	0.2	0.1	0.4	10,853	5427	21,707
France	64,932,339^a	0.68	0.44	1.05	441,540	285,702	681,790
Germany	80,219,695^a	0.6	0.4	0.8	481,318	320,879	641,758
Greece	11,090,000^b	2.33	1.54	3.11	258,397	170,786	344,899
Hungary	9,908,798	1.08	0.04	2.11	107,015	3964	209,076
Iceland	321,857	0.55	0.34	0.71	1770	1094	2285
Ireland	4591,087	0.1	0	0.3	4591	0	13,773
Italy	59,685,227	1.89	1.26	2.52	1,128,051	752,034	1,504,068
Latvia	2,023,825	1.39	1.10	1.67	28,131	22,262	33,798
Liechtenstein	36,838	0.55	0.34	0.71	203	125	262
Lithuania	2,971,905 ^d	2.03	1.37	2.69	60,330	40,715	79,944
Luxembourg	506,953^c	0.55	0.34	0.71	2788	1724	3599
Malta	417,432	0.55	0.34	0.71	2296	1419	2964
Netherlands	16,779,575	0.1	0	0.2	16,780	0	33,559
Norway	5,049,223	0.55	0.34	0.71	27,771	17,167	35,849
Poland	38,533,299	1.44	1.16	1.72	554,880	446,986	662,773
Portugal	10,562,178^a	1.35	0.66	2.04	142,589	69,710	215,468
Romania	20,020,074	5.49	5.24	5.73	1,099,102	1,049,052	1,147,150
Slovakia	5,410,836	0.70	0.43	0.98	37,876	23,267	53,026
Slovenia	2,058,821	3.29	2.33	4.24	67,735	47,971	87,294
Spain	46,727,890	0.66	0.34	0.97	308,404	158,875	453,261
Sweden	9,555,893	0.2	0.1	0.4	19,112	9556	38,224
United Kingdom	63,182,180^a	0.54	0.30	0.60	341,184	189,547	379,093
EU/EEA^e	509,474,165	1.12	0.79^e	1.47^e	5,705,260	4,003,937	7,514,179

^*Source is EUROSTAT 2013 unless indicated by the following symbol:

^aESS 2011 Census

^bOECD 2012

^cOECDC 2010

^dhttp:///www.euras.lt (Lithuanian National Statistics Agency

^eFor the 31 EU/EEA countries the cumulative HBsAg prevalence and the upper and lower CI were estimated from the sum of the estimated number of CHB cases (central, lower and upper estimate), hence these should be considered as upper and lower prevalence ranges and not CI